Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polypharmacology: The science of multi-targeting molecules
Abbas Kabir, Aaron Muth
Pharmacological Research (2022) Vol. 176, pp. 106055-106055
Closed Access | Times Cited: 101

Showing 26-50 of 101 citing articles:

Polypharmacology: new drugs in 2023–2024
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
Tyrosine and proline conjugated trolox, hydroxy-cinnnamic acid and diclofenac hybrids as strong hypolipidemic and anti-inflammatory agents.
Panagiotis Theodosis‐Nobelos, Eleni A. Rekka
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130194-130194
Closed Access
Marine-Derived Bioactive Compounds: A Promising Strategy for Ameliorating Skeletal Muscle Dysfunction in COPD
Meiling Jiang, Peijun Li, Xiaoyu Han, et al.
Marine Drugs (2025) Vol. 23, Iss. 4, pp. 158-158
Open Access
Clinical evidence construction of East Asian herbal medicine for inflammatory pain in rheumatoid arthritis based on integrative data mining approach
Hee-Geun Jo, Jihye Seo, Donghun Lee
Pharmacological Research (2022) Vol. 185, pp. 106460-106460
Closed Access | Times Cited: 20
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease
Kailash Jangid, Bharti Devi, Ashrulochan Sahoo, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 509-527
Closed Access | Times Cited: 12
Anti-parkinsonian, anti-inflammatory, anti-microbial, analgesic, anti-hyperglycemic and anticancer activities of poly-fused ring pyrimidine derivatives
Rawan Bafail, Waad A. Samman
Tropical Journal of Pharmaceutical Research (2024) Vol. 23, Iss. 1, pp. 67-75
Open Access | Times Cited: 4
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function
Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler, et al.
Life Science Alliance (2024) Vol. 7, Iss. 8, pp. e202402671-e202402671
Open Access | Times Cited: 4
Unveiling the mechanism of action of a novel natural dual inhibitor of SARS-CoV-2 Mpro and PLpro with molecular dynamics simulations
Xiaoxia Gu, Xiaotian Zhang, Xueke Zhang, et al.
Natural Products and Bioprospecting (2025) Vol. 15, Iss. 1
Open Access
A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy
Huan Xiao, Aoxue Wang, Shuai Wen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Polypharmacological Cell-Penetrating Peptides from Venomous Marine Animals Based on Immunomodulating, Antimicrobial, and Anticancer Properties
Shiva Hemmati, Haniyeh Rasekhi Kazerooni
Marine Drugs (2022) Vol. 20, Iss. 12, pp. 763-763
Open Access | Times Cited: 17
Development of Computational In Silico Model for Nano Lipid Carrier Formulation of Curcumin
Omar Waleed Abduljaleel Albasri, Palanirajan Vijayaraj Kumar, Mogana Rajagopal
Molecules (2023) Vol. 28, Iss. 4, pp. 1833-1833
Open Access | Times Cited: 10
Dual-target drugs against Leishmania donovani for potential novel therapeutics
Kushal Bora, Manash Pratim Sarma, Shankar Prasad Kanaujia, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Synthesis and bioevaluation of novel stilbene-based derivatives as tubulin/HDAC dual-target inhibitors with potent antitumor activities in vitro and in vivo
Huajian Zhu, Wenjian Zhu, Yang Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115529-115529
Open Access | Times Cited: 9
Synthesis, molecular docking and pharmacological evaluations of novel naphthalene-pyrazoline hybrids as new orally active anti-inflammatory agents
D Vasudha, A Jagadeesh, Suraj N. Mali, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100500-100500
Open Access | Times Cited: 3
Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals
Alfonso Dueñas‐González, Aurora González‐Fierro, Leticia Bornstein-Quevedo, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 8, pp. 665-677
Closed Access | Times Cited: 3
The New Paradigm in Animal Testing – “3Rs Alternatives”
Wen Tsin Poh, Johnson Stanslas
Regulatory Toxicology and Pharmacology (2024), pp. 105705-105705
Closed Access | Times Cited: 3
Identification of KW-2449 as a dual inhibitor of ferroptosis and necroptosis reveals that autophagy is a targetable pathway for necroptosis inhibitors to prevent ferroptosis
Yaxing Zhao, Qingsong Wang, Jing Zhu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 3
Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections
Na Liu, Jie Tu, Yahui Huang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114819-114819
Closed Access | Times Cited: 8
Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective
Varun Aggarwal, Ekta Bala, Pawan Kumar, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1664-1698
Closed Access | Times Cited: 6
Cross-view contrastive representation learning approach to predicting DTIs via integrating multi-source information
Chengxin He, Yuening Qu, Jin Yin, et al.
Methods (2023) Vol. 218, pp. 176-188
Closed Access | Times Cited: 6
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity
Manar G. Salem, Sara A. Abu El-ata, Elsherbiny H. Elsayed, et al.
RSC Advances (2023) Vol. 13, Iss. 47, pp. 33080-33095
Open Access | Times Cited: 6
Target identification by structure-based computational approaches: Recent advances and perspectives
Simona De Vita, Maria Giovanna Chini, Giuseppe Bifulco, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 83, pp. 129171-129171
Open Access | Times Cited: 5
Novel Computational Methods for Cancer Drug Design
Sekhar Talluri, Mohammad Amjad Kamal, Rama Rao Malla
Current Medicinal Chemistry (2023) Vol. 31, Iss. 5, pp. 554-572
Closed Access | Times Cited: 5
Developing kinase inhibitors for malaria: an opportunity or liability?
Koketso S.P. Mogwera, Kelly Chibale, Lauren B. Arendse
Trends in Parasitology (2023) Vol. 39, Iss. 9, pp. 720-731
Closed Access | Times Cited: 5
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
Jing Lu, Ying Zhang, Chunyan Yan, et al.
Bioactive Materials (2024) Vol. 45, pp. 567-583
Closed Access | Times Cited: 1

Scroll to top